| Stanley Cohen, MD | |
|
150 Bergen St, Newark, NJ 07103-2496 | |
| (973) 972-4145 | |
| (973) 972-5909 |
| Full Name | Stanley Cohen |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology |
| Location | 150 Bergen St, Newark, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093740672 | NPI | - | NPPES |
| 6651500 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 25MA06098000 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stanley Cohen, MD 30 Bergen St, Admc 12 1205, Newark, NJ 07107-3000 Ph: () - | Stanley Cohen, MD 150 Bergen St, Newark, NJ 07103-2496 Ph: (973) 972-4145 |
News Archive
New analyses of the largest-ever clinical trial of patients with type 2 diabetes show that the combination of blood pressure lowering treatment and intensive glucose (blood sugar) control improved patients' vascular condition and resulted in a significant 18 percent reduction in the risk of death from all causes.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that a presentation of results from its Phase 3 clinical trial of Lymphoseek (technetium 99m tilmanocept) Injection in patients with head and neck squamous cell carcinoma received the 1st Investigator Award at the 2nd InternationaI Symposium on Thoracic and Upper Aerodigestive Malignancies.
New research reveals a perceived lack of support from family and friends affects a patient's ability to manage type 2 diabetes, according to a study published in The Journal of the American Osteopathic Association.
Teva Pharmaceutical Industries Ltd. today announced the publication of data from the 15-year clinical study with Copaxone® (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis (RRMS) patients. The data were published in the February issue of the journal Multiple Sclerosis.
› Verified 7 days ago
Dr. Jie-gen Jiang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 150 Bergen Street, Newark, NJ 07103 Phone: 973-972-4083 Fax: 973-972-5909 | |
Xinlai Sun, MD Pathology Medicare: Medicare Enrolled Practice Location: 201 Lyons Ave # L-4, Newark, NJ 07112 Phone: 973-926-7580 Fax: 973-705-8301 | |
George P. Studzinski, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 150 Bergen St, Newark, NJ 07103 Phone: 973-972-5869 Fax: 973-972-5909 | |
Seena Carol Aisner, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 30 Bergen St, Admc 12 1205, Newark, NJ 07107 Phone: 973-972-0037 | |
Leroy Ralph Sharer, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 150 Bergen St, Newark, NJ 07103 Phone: 973-972-4770 Fax: 973-972-5933 | |
Fermina M Mazzella, MD Pathology Medicare: Medicare Enrolled Practice Location: 150 Bergen St, Room C-102, Newark, NJ 07103 Phone: 973-972-4619 Fax: 973-972-3199 |